Juichi Fujimori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Juichi Fujimori has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ichiro Nakashima
Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan
4 shared publications Kazuo Fujihara
Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan
2 shared publications- Kazuo Fujihara
Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Japan
2 shared publications - Tatsuro Misu
Department of Neurology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan
2 shared publications Hiroshi Kuroda
Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan
1 shared publicationIchiro Nakashima
Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan
1 shared publication
Latest Publications
- 29 February 2016
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 4 (2) , 79-80
Subacute cerebellar atrophy in a patient with systemic lupus erythematosus after Herpes zoster infection
- 29 February 2016
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 4 (2) , 79-80
Subacute cerebellar atrophy in a patient with systemic lupus erythematosus after Herpes zoster infection
- 16 November 2014
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 3 (2) , 84
Delayed syringomyelia as a result of spinal adhesive arachnoiditis after tuberculous meningitis
- 16 November 2014
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 3 (2) , 84
Delayed syringomyelia as a result of spinal adhesive arachnoiditis after tuberculous meningitis
- 1 August 2014
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 273 (1-2) , 77-84
Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitis
- 1 August 2014
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 273 (1-2) , 77-84
Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitis
- 1 December 2011
- p. 470-3
[Cognitive impairment in demyelinating disease].
- 1 June 2004
- Vol. 56 (6) , 475-82
[Multiple sclerosis and oligoclonal IgG bands].
- 1 November 2002
- Vol. 42 (11) , 1195-7
[Pathogenesis of optic-spinal MS].
We reviewed the clinical and immunological features of optic-spinal multiple sclerosis (OSMS), or relapsing neuromyelitis optica. OSMS has collected much attention as to whether it is a distinct entity from conventional MS (CMS). However, OSMS plus minor cerebral and brainstem/cerebellar involvement and the later conversion into CMS had been a diagnostic dilemma. To overcome such problems and delineate the features of OSMS, we analyzed 'Pure OSMS' with which patients had only relapsing optic neuritis and myelitis clinically and consistently normal brain MRI during 5 years or longer follow-ups. As a result, we found that this type of MS was characterized by a definite female preponderance and negative oligoclonal IgG bands (OB), although 'Pure OSMS' was heterogeneous with regards to the clinical severity and HLA class II alleles. Previously reported immunological data in OSMS include negative OB and no elevation of IL-10 or matrix metalloproteinase-9 in the cerebrospinal fluid (CSF) during relapses. In addition, we recently demonstrated that the CCR5+ Th1 cell subset in CSF during relapses, which significantly increased in CMS, remained low in OSMS. These unique clinical and immunological findings probably relate to fundamental differences in the pathogeneses of OSMS and CMS and deserve further characterization.
- 1 November 2002
- Vol. 42 (11) , 1195-7
[Pathogenesis of optic-spinal MS].
We reviewed the clinical and immunological features of optic-spinal multiple sclerosis (OSMS), or relapsing neuromyelitis optica. OSMS has collected much attention as to whether it is a distinct entity from conventional MS (CMS). However, OSMS plus minor cerebral and brainstem/cerebellar involvement and the later conversion into CMS had been a diagnostic dilemma. To overcome such problems and delineate the features of OSMS, we analyzed 'Pure OSMS' with which patients had only relapsing optic neuritis and myelitis clinically and consistently normal brain MRI during 5 years or longer follow-ups. As a result, we found that this type of MS was characterized by a definite female preponderance and negative oligoclonal IgG bands (OB), although 'Pure OSMS' was heterogeneous with regards to the clinical severity and HLA class II alleles. Previously reported immunological data in OSMS include negative OB and no elevation of IL-10 or matrix metalloproteinase-9 in the cerebrospinal fluid (CSF) during relapses. In addition, we recently demonstrated that the CCR5+ Th1 cell subset in CSF during relapses, which significantly increased in CMS, remained low in OSMS. These unique clinical and immunological findings probably relate to fundamental differences in the pathogeneses of OSMS and CMS and deserve further characterization.